Clinical trial
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
NCT00108849 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00108849 |
|---|---|
| Title | Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms |
| Official title | A 12 Month Double-blind, Randomized, Parallel-group, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose (10 mcg 17beta-estradiol Vaginal Tablet) for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Postmenopausal Vaginal Atrophy |
| Intervention type | Drug |
| Interventions | estradiol, 10 mcg |
| Enrollment | 309 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Apr 20, 2005 |
| Last update posted | Feb 8, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: